Precision BioSciences, Inc. (DTIL)
7.78
-0.62
(-7.38%)
USD |
NASDAQ |
Aug 28, 16:00
7.80
+0.02
(+0.26%)
After-Hours: 20:00
Precision BioSciences 1 Year Total Returns (Daily) : 54.98% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 54.98% |
| August 27, 2026 | 67.66% |
| August 26, 2026 | 68.45% |
| August 25, 2026 | 66.67% |
| August 24, 2026 | 70.36% |
| August 21, 2026 | 86.71% |
| August 20, 2026 | 87.12% |
| August 19, 2026 | 77.08% |
| August 18, 2026 | 66.26% |
| August 17, 2026 | 57.11% |
| August 14, 2026 | 55.77% |
| August 13, 2026 | 55.65% |
| August 12, 2026 | 69.41% |
| August 11, 2026 | 72.64% |
| August 10, 2026 | 70.32% |
| August 07, 2026 | 63.90% |
| August 06, 2026 | 54.26% |
| August 05, 2026 | 53.70% |
| August 04, 2026 | 50.41% |
| August 03, 2026 | 52.81% |
| July 31, 2026 | 47.16% |
| July 30, 2026 | 45.83% |
| July 29, 2026 | 40.90% |
| July 28, 2026 | 40.59% |
| July 27, 2026 | 40.78% |
| Date | Value |
|---|---|
| July 24, 2026 | 45.80% |
| July 23, 2026 | 48.38% |
| July 22, 2026 | 50.62% |
| July 21, 2026 | 63.87% |
| July 20, 2026 | 59.65% |
| July 17, 2026 | 69.61% |
| July 16, 2026 | 84.07% |
| July 15, 2026 | 97.98% |
| July 14, 2026 | 84.91% |
| July 13, 2026 | 93.03% |
| July 10, 2026 | 81.37% |
| July 09, 2026 | 93.66% |
| July 08, 2026 | 105.3% |
| July 07, 2026 | 114.6% |
| July 06, 2026 | 89.86% |
| July 02, 2026 | 92.02% |
| July 01, 2026 | 90.80% |
| June 30, 2026 | 87.14% |
| June 29, 2026 | 84.19% |
| June 26, 2026 | 76.09% |
| June 25, 2026 | 59.20% |
| June 24, 2026 | 47.48% |
| June 23, 2026 | 53.42% |
| June 22, 2026 | 47.81% |
| June 18, 2026 | 44.89% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Amgen, Inc. | 55.58% |
| 4D Molecular Therapeutics, Inc. | 137.4% |
| Agenus, Inc. | 80.24% |
| Anika Therapeutics, Inc. | 128.6% |
| BioCryst Pharmaceuticals, Inc. | 15.94% |